Announcements
- Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
- Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference
- Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
- Cue Biopharma to Host Business Update Call and Webcast
- Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium
- Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit
- Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
More ▼
Key statistics
As of last trade, Cue Biopharma Inc (1UC:BER) traded at 1.58, 27.42% above the 52 week low of 1.24 set on Apr 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.61 |
---|---|
High | 1.61 |
Low | 1.51 |
Bid | 1.50 |
Offer | 1.63 |
Previous close | 1.59 |
Average volume | 166.67 |
---|---|
Shares outstanding | 48.64m |
Free float | 48.31m |
P/E (TTM) | -- |
Market cap | 84.64m USD |
EPS (TTM) | -1.07 USD |
Data delayed at least 15 minutes, as of May 24 2024 16:42 BST.
More ▼